Page 188 - PRECONGRESS COURSE 06

Supplementation of luteal phase with hCG after GnRH agonist triggering in low risk for OHSS patients
Conclusions
Severe OHSS is possible
after GnRH agonist triggering even in low risk patients,
when two doses of 1500 IU of hCG are administered in the luteal phase
Supplementation of luteal phase with hCG after GnRH agonist triggering in high risk for OHSS patients
70
65
60
55
50
45
40
35 34.4 30
25 20 15 10
5 0
52.1
Clinical pregnancy
42.6
500 IU Cas llo 2010
1500 IU Humaidan 1500 IU Radesic & 2013 Tremellen 2011
39.4
250 IU Cas llo 2010
47.7
1000 IU Cas llo 2010
22.2
1500 IU Seyhan 2013
188
Page 184 of 258
Clinical pregnancy % 95% CI